1. 126TiP A phase I study of NBTXR3 activated by radiotherapy for patients with advanced cancers treated with an anti-PD-1 therapy. (15th December 2019) Authors: Shen, C; Jameson, K; Weiss, J; Hackman, T; Corum, D; Akulian, J A; Dixon, R; Pearson, A; Frakes, J; Said, P; Miraoui, H; Baskin-Bey, E; Seiwert, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy. (8th November 2018) Authors: Chen, Y -P; Wang, Y -Q; Lv, J -W; Li, Y -Q; Chua, M L K; Le, Q -T; Lee, N; Colevas, A Dimitrios; Seiwert, T; Hayes, D N; Riaz, N; Vermorken, J B; O'Sullivan, B; He, Q -M; Yang, X -J; Tang, L -L; Mao, Y -P; Sun, Y; Liu, N; Ma, J Journal: Annals of oncology Issue: Volume 30:Number 1(2019) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗